Tissue Factor Pathway Inhibitor 2 Is Found in Skin and Its C-Terminal Region Encodes for Antibacterial Activity

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Papareddy, Praveen ^a   Kalle, Martina ^a   Sørensen, Ole E ^a   Lundqvist, Katarina ^a   Mörgelin, Matthias ^a   Malmsten, Martin ^b   Schmidtchen, Artur ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EDC34 PROTEIN; FIBRIN; LEUKOCYTE ELASTASE; LIPOSOME; PLACENTA PROTEIN 5; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PERMEABILIZATION; CONTROLLED STUDY; GENETIC CODE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN INTERACTION; SKIN; UPREGULATION; WOUND;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS SUBTILIS; CANDIDA ALBICANS; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDES; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PSEUDOMONAS AERUGINOSA; SKIN; STAPHYLOCOCCUS AUREUS; TISSUE CULTURE TECHNIQUES;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 84871580176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052772     Document Type: Article

References (39)

1. Boman HG, (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254: 197-215.
2. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
3. Lehrer RI, Ganz T, (2002) Defensins of vertebrate animals. Curr Opin Immunol 14: 96-102.
4. Oppenheim JJ, Yang D, (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17: 359-365.
5. Harder J, Schroder JM, (2005) Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77: 476-486.
6. Glaser R, Harder J, Lange H, Bartels J, Christophers E, et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6: 57-64.
7. Nordahl EA, Rydengard V, Nyberg P, Nitsche DP, Morgelin M, et al. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879-16884.
8. Papareddy P, Rydengard V, Pasupuleti M, Walse B, Morgelin M, et al. (2010) Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog 6: e1000857.
9. Frick IM, Akesson P, Herwald H, Morgelin M, Malmsten M, et al. (2006) The contact system-a novel branch of innate immunity generating antibacterial peptides. EMBO J 25: 5569-5578.
10. Malmstrom E, Morgelin M, Malmsten M, Johansson L, Norrby-Teglund A, et al. (2009) Protein C inhibitor-a novel antimicrobial agent. PLoS Pathog 5: e1000698.
11. Tang YQ, Yeaman MR, Selsted ME, (2002) Antimicrobial peptides from human platelets. Infect Immun 70: 6524-6533.
12. Riedel T, Suttnar J, Brynda E, Houska M, Medved L, et al. (2011) Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 117: 1700-1706.
13. Papareddy P, Kalle M, Kasetty G, Morgelin M, Rydengard V, et al. (2010) C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules. J Biol Chem 285: 28387-28398.
14. Chand HS, Foster DC, Kisiel W, (2005) Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost 94: 1122-1130.
15. Sprecher CA, Kisiel W, Mathewes S, Foster DC, (1994) Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A 91: 3353-3357.
16. Udagawa K, Miyagi Y, Hirahara F, Miyagi E, Nagashima Y, et al. (1998) Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization. Placenta 19: 217-223.
17. Iino M, Foster DC, Kisiel W, (1998) Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler Thromb Vasc Biol 18: 40-46.
18. Rao CN, Liu YY, Peavey CL, Woodley DT, (1995) Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts. Arch Biochem Biophys 317: 311-314.
19. Rao CN, Peavey CL, Liu YY, Lapiere JC, Woodley DT, (1995) Partial characterization of matrix-associated serine protease inhibitors from human skin cells. J Invest Dermatol 104: 379-383.
20. Rao CN, Reddy P, Liu Y, O'Toole E, Reeder D, et al. (1996) Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys 335: 82-92.
21. Rao CN, Gomez DE, Woodley DT, Thorgeirsson UP, (1995) Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys 319: 55-62.
22. Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, et al. (1996) Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 35: 266-272.
23. Kong D, Ma D, Bai H, Guo H, Cai X, et al. (2004) Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2. Biochem Biophys Res Commun 324: 1179-1185.
24. Hisaka T, Lardeux B, Lamireau T, Wuestefeld T, Lalor PF, et al. (2004) Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during inflammation. Thromb Haemost 91: 569-575.
25. Torres-Collado AX, Kisiel W, Iruela-Arispe ML, Rodriguez-Manzaneque JC, (2006) ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J Biol Chem 281: 17827-17837.
26. Carlemalm E, Villiger W, Hobot JA, Acetarin JD, Kellenberger E, (1985) Low temperature embedding with Lowicryl resins: two new formulations and some applications. J Microsc 140: 55-63.
27. Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, et al. (2010) Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol 130: 1167-1177.
28. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37: D868-872.
29. Tossi A, Sandri L, Giangaspero A, (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55: 4-30.
30. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
31. Huang HW, (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758: 1292-1302.
32. Stromstedt AA, Wessman P, Ringstad L, Edwards K, Malmsten M, (2007) Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J Colloid Interface Sci 311: 59-69.
33. Ramamoorthy A, Thennarasu S, Lee DK, Tan A, Maloy L, (2006) Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys J 91: 206-216.
34. Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M, (2007) Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J 92: 87-98.
35. Ringstad L, Kacprzyk L, Schmidtchen A, Malmsten M, (2007) Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 1768: 715-727.
36. Ringstad L, Schmidtchen A, Malmsten M, (2006) Effect of Peptide Length on the Interaction between Consensus Peptides and DOPC/DOPA Bilayers. Langmuir 22: 5042-5050.
37. Ringstad L, Protopapa E, Lindholm-Sethson B, Schmidtchen A, Nelson A, et al. (2008) An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 24: 208-216.
38. Chen FY, Lee MT, Huang HW, (2003) Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 84: 3751-3758.
39. Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A, (2005) Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 280: 34832-34839.